EXLSERVICE HOLDINGS, INC. (EXLS): what the price requires
At today's price, EXLSERVICE HOLDINGS, INC. (EXLS) is priced for +3.1% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/EXLS
Headline
| Field | Value |
|---|---|
| Ticker | EXLS |
| Company | EXLSERVICE HOLDINGS, INC. |
| Current price | $28.37/sh |
| Composition | Insurance 41% / Healthcare and Life Sciences 31% / Banking, Capital Markets and Diversified Industries 28% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 2.5% |
| Operating margin today | 15.5% |
| Margin compression implied | -13.0pp |
| Implied growth | 3.1% |
| Multiple paid | 14x operating income |
The operating-margin requirement is derived from the framework's value band at year 9, a separately labeled basis from the headline growth/duration solve.
Solve inputs: computed at a 8.7% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~6.1pp.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | -0.85σ |
| cohort percentile (of 210 peers) | 31 |
| implied end-window share | 0% |
Valuation X-Ray
The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.64x | 5 | expensive |
| Earnings | 1.67x | 5 | expensive |
| Relative | 0.88x | 5 | justifies |
| Growth | 0.77x | 3 | justifies |
Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.3%); the inversion above states its own rate.
Per-Model Detail (n=18)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $53.87 | 0.53x | yes | FCF base $0.3B, growth 13% (input: historical growth), terminal g 4.0%, WACC 8.3%, 6yr projection |
| DCF Exit Multiple | Growth | $37.06 | 0.77x | yes | Exit EV/EBITDA: 10.5x / 12.5x / 14.5x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $34.25 | 0.83x | yes | P/E 20x (static sector reference · 2026-04), scenarios: 16.5x / 20.0x / 23.5x (bear / base = reference held flat / bull), EV/EBITDA 14x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $17.33 | 1.64x | yes | BV/sh $4.96, ROE (TTM) 32.3%, ke 9.3% |
| Two-Stage Excess Return | Asset | $33.92 | 0.84x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $24.31 | 1.17x | yes | Rev $2.2B, growth 13% (input: historical growth; tapered), Terminal P/S: 1.7x / 2.1x / 2.4x (bear / base = today's held flat / bull, cap 12x) |
| Peter Lynch Fair Value | Relative | $32.20 | 0.88x | yes | EPS $1.57, growth 21% (input: historical EPS growth), PEG=0.86 (Undervalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $11.10 | 2.56x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.24B × (1−21%) / WACC 8.3% → EPV (no growth) |
| Residual Income | Asset | $26.72 | 1.06x | yes | BV $4.96 + 5yr PV of (ROE (TTM) 32.3% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $13.24 | 2.14x | yes | √(22.5 × EPS $1.57 × BVPS $4.96) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $32.11 | 0.88x | yes | EBITDA $0.39B × sector EV/EBITDA 14.0x |
| FCF Yield | Earnings | $18.03 | 1.57x | yes | FCF $296.6M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $12.35 | 2.30x | yes | SBC-adj FCF $0.21B (FCF $0.30B − SBC $0.08B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $50.66 | 0.56x | yes | EPS $1.57 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $3.73 | 7.61x | yes | BV $4.96 × (ROIC 6.3% / WACC 8.3%) |
| P/Sales Sector | Relative | $20.62 | 1.38x | yes | Revenue $2.16B × sector P/S 1.5x |
| PEG Fair Value | Relative | $48.29 | 0.59x | yes | EPS $1.57 × (PEG 1.5 × growth 20.5% (input: historical EPS growth)) → PE 30.8x |
| Earnings Yield | Earnings | $16.97 | 1.67x | yes | EPS $1.57 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $165.8m |
| Net debt / NOPAT (after-tax) | 0.64x |
| Net debt / operating income (pre-tax) | 0.51x |
| Interest coverage | 18.9x |
| Share count CAGR (buyback) | -1.9% |
| Burning cash | no |
Bullet Takeaways
- ExlService is a data analytics and digital operations firm for insurers, healthcare, and banks, embedding "deep domain expertise with AI-driven decision-making" into client workflows rather than selling generic outsourcing.
- The biggest specific risk is the same technology that drives growth: the filing concedes a client "may choose to use its own internal resources rather than engage an" outside provider, so generative and agentic AI could let clients do in-house what they now pay EXL to do.
- What moves the stock next is the AI mix shift: data and AI-led revenues grew 28% year over year to about 60% of the total, and management raised full-year 2026 guidance to revenue of $2.30 to $2.33 billion and adjusted EPS of $2.18 to $2.23.
Bull Case
Begin with the bear's strongest argument, because the data answers it. The obvious fear for any analytics and operations firm is that artificial intelligence collapses the work, letting clients automate in-house what they currently outsource. ExlService's own filing names that risk plainly. But the most recent quarter shows EXL as the one wielding the technology rather than being displaced by it: data and AI-led revenues grew 28% year over year and now make up roughly 60% of total revenue, as clients "adopt scaled AI in regulated workflows" and move work from lower-value operations toward higher-value AI engagements. The company describes embedding "deep domain expertise with AI-driven decision-making" into its clients' processes, which is precisely the moat AI threatens for generic vendors and reinforces for specialists who own the domain knowledge and the data.
The financial profile is that of a high-quality compounder, not a commodity outsourcer. EXL earns a return on equity above 30%, runs an adjusted operating margin around 20%, and converts its earnings into real free cash flow of nearly $300 million, all on a balance sheet with almost no net leverage and interest coverage near 19 times. The first quarter delivered revenue of $570.4 million, up about 14%, and management raised full-year guidance to $2.30 to $2.33 billion in revenue and adjusted EPS of $2.18 to $2.23, implying double-digit organic growth and double-digit EPS growth. A services firm growing at low-to-mid teens with a 30%-plus return on equity is monetizing knowledge, not just labor hours.
Capital allocation reinforces the story. EXL repurchased 4.4 million shares for about $136 million in the quarter, continuing to shrink the share count, and it is investing in AI and research even as it does so, accepting a modest near-term margin step-down to fund the capability that drives the growth. The X-ray reflects a price that is not stretched: the relative-multiple and forward-growth methods reach it, and the implied operating growth embedded in the price is only about 1% a year, far below what the company is actually delivering. The bull case is that EXL is an AI winner trading as if AI were a threat.
Bear Case
The structural risk for ExlService is not its balance sheet, which is clean; it is the durability of the business model in an AI world, and that risk is genuine even as the company rides AI today. The same technology that is lifting EXL's revenue lowers the barrier for its clients to bring work back in-house. The filing is candid that a client "may choose to use its own internal resources rather than engage an" external partner, and it lists among the variables it must manage "anticipating and incorporating the latest technologies, for instance, artificial intelligence ('AI'), including generative AI, agentic AI into our offerings". If agentic AI matures faster than EXL's domain moat deepens, the very workflows it embeds itself in could become cheap enough for clients to automate without it. A firm that grows by selling AI-enabled services lives one technology shift away from its clients no longer needing the service.
The economics carry the fingerprints of that pressure. Management guided to an adjusted operating margin stepping down to the mid-19% range for the rest of 2026 as it increases AI and research spending, which is the cost of staying ahead of the disruption. That is a treadmill: the investment that keeps EXL relevant also caps the margin expansion a shareholder might otherwise expect from a growing, capital-light business. Client concentration in regulated industries adds another edge; a large insurance or banking client deciding to internalize or switch providers can move the numbers, and pricing pressure is constant in a field where "AI solutions, industry knowledge, service quality, compliance rigor, global delivery capabilities, pricing" are all competitive battlegrounds.
The valuation, read through the most conservative method, says the same thing the model risk does. The earnings-power lens reads the price as expensive, because it capitalizes a five-year average operating income against a price that already credits continued growth. The bear case is not that EXL is overvalued on today's numbers; the relative and growth methods support the price. It is that a business whose growth and whose obsolescence both run on the same technology is harder to underwrite than the clean financials suggest, and the market is paying as if the AI tailwind is durable and the AI threat is not.
Valuation
The price embeds a strikingly modest assumption: at roughly 13 times company-wide operating income, the implied operating growth is only about 1% a year for five years. ExlService is growing revenue at low-to-mid teens and guiding to double-digit EPS growth, so the embedded bar sits well below what the company is delivering. That gap is the heart of the valuation case; the price is not asking the business to accelerate, only to keep going.
The methods divide the way they do for a high-return, asset-light services firm. The relative-multiple and forward-growth families reach the price, while the earnings-power lens reads it as expensive. The reason is mechanical: the earnings-power method capitalizes a five-year average operating income with no growth, which structurally understates a company earning a 30%-plus return on equity and growing, and which cannot credit the AI mix shift now driving the business. The peer cohort offered here is a grab-bag of payments and marketplace names rather than direct analytics comparables, so the cleaner read is the absolute one: 13 times operating income for a business compounding revenue in the low-to-mid teens with a high return on equity is not a demanding price, and the spread between the cheap embedded growth and the actual growth is the opportunity the bull points to.
Solvency is a strength and removes the financial tail risk. Net debt sits at roughly half a year of operating income, interest coverage runs near 19 times, the company generates strong free cash flow, and it is buying back stock. The balance sheet can fund the AI and research investment internally and still return capital. What solvency cannot resolve is the model question: the price is supported on current economics, but the durability of those economics depends on EXL staying the user of AI rather than its victim. The buyer is underwriting that distinction more than any balance-sheet risk.
Catalysts
The first quarter of 2026 advanced the AI transition that is the core of the story. ExlService reported revenue of $570.4 million, up about 14% year over year, with adjusted EPS of $0.58, and data and AI-led revenues grew 28% to roughly 60% of total revenue as clients adopted scaled AI in regulated workflows. Management raised full-year 2026 guidance to revenue of $2.30 to $2.33 billion and adjusted diluted EPS of $2.18 to $2.23, implying 10% to 12% constant-currency organic growth and 12% to 14% EPS growth. The margin guide stepped to the mid-19% range for the rest of the year to fund increased AI and research investment.
Capital return continued, with 4.4 million shares repurchased for about $136 million in the quarter. Analyst sentiment is bullish, with a Strong Buy consensus and targets well above the current price, in the high $40s to low $50s. The catalysts that matter from here are the continued mix shift toward AI-led revenue and whether the margin holds near the guided range as the investment ramps. Because the business and its central risk both run on AI, the key signal each quarter is the same: whether the AI revenue growth keeps outpacing the threat that clients automate the work themselves.
Peer Cohorts (Per Segment, With Filing Citations)
Insurance / Healthcare and Life Sciences +2 more (reported)
- G (GENPACT LIMITED)
- (no filing in the citation store)
- CNXC (CONCENTRIX CORPORATION)
- (no filing in the citation store)
- MMS (Maximus, Inc.)
- (no filing in the citation store)
- CTSH (COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION)
- (no filing in the citation store)
- ACN (Accenture plc)
- (no filing in the citation store)
- DXC (DXC Technology Co)
- (no filing in the citation store)
- CBZ (CBIZ, Inc.)
- (no filing in the citation store)
- BR (BROADRIDGE FINANCIAL SOLUTIONS, INC.)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Q1 2026 results, April 2026 · analyst consensus, 2026